Ezetimibe BE [Regulatives / Guidelines]

posted by Mutasim – Jordan, 2019-09-23 14:40  – Posting: # 20641
Views: 2,508

Dear Members,
Would you please advice on interpretation of the requirements for Ezetimibe BE according to the last guidance by EMA, in particular the statement
"Main pharmacokinetic variables: AUC0-72h, Cmax
Background/justification: On total (parent + glucuronide metabolite together)
Does it mean measuring each one alone? or the total as in FDA guidance? and accordingly will the CI be for each one alone or both unconjugated and total or only total?


Edit: Guideline linked. [Helmut]

Complete thread:

Activity
 Admin contact
20,641 posts in 4,327 threads, 1,437 registered users;
online 53 (0 registered, 53 guests [including 24 identified bots]).
Forum time: 22:53 CEST (Europe/Vienna)

In general, scientific progress calls for no more
than the absorption and elaboration of new ideas 
and this is a call most scientists are happy to heed.    Werner Heisenberg

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5